HK7091A - Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives - Google Patents

Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives

Info

Publication number
HK7091A
HK7091A HK70/91A HK7091A HK7091A HK 7091 A HK7091 A HK 7091A HK 70/91 A HK70/91 A HK 70/91A HK 7091 A HK7091 A HK 7091A HK 7091 A HK7091 A HK 7091A
Authority
HK
Hong Kong
Prior art keywords
hydroxypyrid
derivatives
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
HK70/91A
Other languages
English (en)
Inventor
Robert Charles Hider
George Kontoghiorghes
Jack Silver
Michael Arthur Stockham
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of HK7091A publication Critical patent/HK7091A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
HK70/91A 1983-09-23 1991-01-24 Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives HK7091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838325496A GB8325496D0 (en) 1983-09-23 1983-09-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
HK7091A true HK7091A (en) 1991-02-01

Family

ID=10549201

Family Applications (1)

Application Number Title Priority Date Filing Date
HK70/91A HK7091A (en) 1983-09-23 1991-01-24 Pharmaceutical compositions containing 1-hydroxypyrid-2-one derivatives

Country Status (11)

Country Link
US (1) US4587240A (da)
EP (1) EP0138420B1 (da)
JP (2) JPS6094966A (da)
CY (1) CY1574A (da)
DE (1) DE3480599D1 (da)
DK (1) DK161703C (da)
GB (2) GB8325496D0 (da)
GR (1) GR80444B (da)
HK (1) HK7091A (da)
SG (1) SG93290G (da)
ZA (1) ZA847409B (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308055D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308054D0 (en) * 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
GB8329043D0 (en) * 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
US5010191A (en) * 1985-08-19 1991-04-23 The Regents Of The University Of California Imaging agents for in vivo magnetic resonance and scintigraphic imaging
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
US4908371A (en) * 1987-11-10 1990-03-13 Ciba-Geigy Corporation Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload
GB8910521D0 (en) * 1989-05-08 1989-06-21 Nat Res Dev The stabilization of organic compounds
US5443813A (en) * 1991-06-06 1995-08-22 Associated Universities, Inc. Loading and conjugating cavity biostructures
AU6010696A (en) 1995-06-10 1997-01-09 Vitra Pharmaceuticals Ltd Iron compounds, compositions, methods of making the same and uses thereof
US5667933A (en) * 1996-02-26 1997-09-16 Polaroid Corporation Image-recording element
GB9625638D0 (en) * 1996-12-10 1997-01-29 Cenes Ltd Therapeutic antioxidants for alzheimer's diease
EP1158985B1 (en) 1999-01-13 2011-12-28 Bayer HealthCare LLC OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
WO2002024196A1 (en) * 2000-09-19 2002-03-28 Vitra Pharmaceuticals Limited Iron compositions
EP1478358B1 (en) 2002-02-11 2013-07-03 Bayer HealthCare LLC Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
GB0211500D0 (en) * 2002-05-18 2002-06-26 Vitra Pharmaceuticals Ltd Method of forming iron hydroxypyrone compounds
US7595073B2 (en) * 2003-02-28 2009-09-29 Kraft Foods Global Brands Llc Use of siderophores and organic acids to retard lipid oxidation
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
CA2526636C (en) 2003-05-20 2012-10-02 Bayer Pharmaceuticals Corporation Diaryl ureas for diseases mediated by pdgfr
CL2004001834A1 (es) 2003-07-23 2005-06-03 Bayer Pharmaceuticals Corp Compuesto 4-{4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenoxi}-piridin-2-metilamida, inhibidor de la raf, vegfr, p38 y pdgfr quinasas, sus sales; composiicon farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperprol
CA2627529A1 (en) 2007-03-28 2008-09-28 Apotex Technologies Inc. Fluorinated derivatives of deferiprone
SI2268282T1 (sl) 2008-04-25 2015-01-30 Apotex Technologies Inc. Tekoča farmacevtska oblika deferiprona s prijetnim okusom
BR112012000079A2 (pt) 2009-07-03 2017-07-25 Apotex Tech Inc derivados fluorados de 3-hidroxipiridin-4-onas
CN102892415B (zh) 2010-03-23 2016-10-19 维福（国际）股份公司 用于治疗和预防铁缺乏症状及缺铁性贫血的Fe(Ⅲ)配合物化合物
TWI510496B (zh) * 2011-03-29 2015-12-01 Vifor Int Ag 用於治療及預防鐵缺乏症狀及缺鐵性貧血之Ｆｅ（ＩＩＩ）錯化合物
EP2714030B1 (de) 2011-05-31 2015-08-12 Vifor (International) AG Fe(iii)-2,4-dioxo-1-carbonyl-komplexverbindungen zur verwendung bei der behandlung und der prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
WO2013150087A1 (de) * 2012-04-05 2013-10-10 Vifor (International) Ag Fe (iii) - pyrazin - komplexverbindungen zur behandlung und prophylaxe von eisenmangelerscheinungen und eisenmangelanämien
MX2015007974A (es) 2012-12-21 2016-03-09 Vifor Int Ag Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de la deficiencia de hierro y las anemias por deficiencia de hierro.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2748142A (en) * 1956-05-29 - process of production
GB778871A (en) * 1955-02-14 1957-07-10 Sadolin & Holmblad As Pyridinediol oxides and acetates thereof and their preparation
GB791719A (en) * 1955-02-15 1958-03-12 Sadolin & Holmblad As Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
GB790584A (en) * 1955-02-15 1958-02-12 Sadolin & Holmblad As Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series
FR3691M (fr) * 1963-05-06 1965-11-15 Olin Mathieson Nouvelle composition pharmaceutique utile en tant que fongicide.
NL156397B (nl) * 1968-08-31 1978-04-17 Hoechst Ag Werkwijze voor het bereiden van preparaten tegen schimmelaandoeningen, gevormde preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen.
US3968118A (en) * 1968-08-31 1976-07-06 Hoechst Aktiengesellschaft Process for the manufacture of 1-hydroxy-2-pyridones
US3705943A (en) * 1969-07-18 1972-12-12 Olin Corp Dialkyltin salts of substituted pyridine-1-oxides as fungicides and bactericides
EG10850A (en) * 1972-03-25 1976-06-30 Hoechst Ag Process for the preparation of 1-hydroxy-pyridones
DE2705562A1 (de) * 1977-02-10 1978-08-17 Basf Ag Verfahren zur herstellung von pyridonen
US4358455A (en) * 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
JPS5832812A (ja) * 1981-08-21 1983-02-25 Lion Corp 毛髪化粧料
GB2117766B (en) * 1982-03-24 1985-08-29 Nat Res Dev Pharmaceutical compositions
GB2118176B (en) * 1982-03-24 1985-12-04 Nat Res Dev Pharmaceutical compositions
DE3278014D1 (en) * 1982-10-01 1988-02-25 Merck & Co Inc Aralkylaminoethanol heterocyclic compounds
GB8325496D0 (en) * 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4698431A (en) * 1985-11-12 1987-10-06 The United States Of America As Represented By The United States Department Of Energy Hydroxypyridonate chelating agents

Also Published As

Publication number Publication date
DK453584D0 (da) 1984-09-21
JPH0811729B2 (ja) 1996-02-07
JPS6094966A (ja) 1985-05-28
US4587240A (en) 1986-05-06
EP0138420A2 (en) 1985-04-24
GB2146990B (en) 1987-05-20
EP0138420B1 (en) 1989-11-29
GB8325496D0 (en) 1983-10-26
JPH05246992A (ja) 1993-09-24
JPH0566385B2 (da) 1993-09-21
DK161703C (da) 1992-01-20
ZA847409B (en) 1986-05-28
SG93290G (en) 1991-01-18
GR80444B (en) 1985-01-23
DE3480599D1 (de) 1990-01-04
GB2146990A (en) 1985-05-01
DK161703B (da) 1991-08-05
GB8423800D0 (en) 1984-10-24
DK453584A (da) 1985-03-24
EP0138420A3 (en) 1987-05-20
CY1574A (en) 1991-12-20

Similar Documents

Publication Publication Date Title
CY1574A (en) Pharmaceutical compositions containing 1-hydroxypyramid-2-one derivatives
GB2136807B (en) Pharmaceutical compositions
GB8423339D0 (en) Pharmaceutical compositions
GB8403668D0 (en) Pharmaceutical compositions
DE3467703D1 (en) Pharmaceutical compositions
GB8313217D0 (en) Pharmaceutical compositions
GB8423799D0 (en) Pharmaceutical compositions
GB8415975D0 (en) Pharmaceutical compositions
GB8308126D0 (en) Pharmaceutical compositions
DE3367849D1 (en) Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives
CY1678A (en) Pharmaceutical compositions
GB2136806B (en) Pharmaceutical compositions
GB8317595D0 (en) Pharmaceutical compositions
CY1503A (en) Pharmaceutical compositions
GB8323553D0 (en) Pharmaceutical compositions
GB8406132D0 (en) Pharmaceutical compositions
EP0136006A3 (en) Pharmaceutical compositions
GB8305697D0 (en) Pharmaceutical compositions
GB8416358D0 (en) Pharmaceutical compositions
GB8300767D0 (en) Pharmaceutical compositions
GB8425250D0 (en) Pharmaceutical compositions
GB2150435B (en) Pharmaceutical compositions
GB8331776D0 (en) Pharmaceutical compositions
GB8325628D0 (en) Pharmaceutical compositions
GB8304870D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
NR Patent deemed never to have been added to the register under section 13(7) of patents (transitional arrangements) rules